Data Integrity & Methodology
Data Sources & Clinical Methodology
Pillora does not invent, synthesize, or manipulate pharmaceutical data. Every single product record, active salt specification, and price ceiling displayed on our platform is sourced directly from verifiable public regulatory documents.
Primary Data Registries
- Drug Regulatory Authority of Pakistan (DRAP): Official Gazette Statutory Regulatory Orders (S.R.O.s), Maximum Retail Price (MRP) notifications, and licensed manufacturer registries (dra.gov.pk).
- US Food & Drug Administration (FDA): National Drug Code (NDC) Directory and Orange Book Approved Drug Products with Therapeutic Equivalence Evaluations (open.fda.gov).
- UK National Health Service (NHS): British National Formulary (BNF) presentation standards published under the Open Government Licence v3.0 (opendata.nhsbsa.net).
- World Health Organization (WHO): 23rd & 24th Model List of Essential Medicines (eEML) (list.essentialmeds.org).
3-Check Bioequivalence Matching Rules
An alternative is qualified as an exact generic substitute only if it meets all three clinical criteria simultaneously:
- Identical Active Chemical Entity: Exact matching of the International Nonproprietary Name (INN) molecule.
- Identical Dosage Strength: Normalized numerical strength equivalence (e.g. 500mg, 20mg).
- Identical Route & Dosage Form: Compatible delivery format (e.g. Tablet to Tablet, Capsule to Capsule).